Literature DB >> 27608172

Epidemiology matters: peering inside the "black box" in economic evaluations of genetic testing.

Scott D Grosse1, Muin J Khoury2.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27608172      PMCID： PMC5459311          DOI： 10.1038/gim.2016.121

Source DB:  PubMed          Journal:  Genet Med        ISSN： 1098-3600            Impact factor:   8.822


× No keyword cloud information.
  14 in total

Review 1.  Challenges of translating genetic tests into clinical and public health practice.

Authors:  Wolf H Rogowski; Scott D Grosse; Muin J Khoury
Journal:  Nat Rev Genet       Date:  2009-07       Impact factor: 53.242

Review 2.  Public health action in genomics is now needed beyond newborn screening.

Authors:  M S Bowen; K Kolor; W D Dotson; R M Ned; M J Khoury
Journal:  Public Health Genomics       Date:  2012-09-11       Impact factor: 2.000

3.  Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome.

Authors:  Valérie Bonadona; Bernard Bonaïti; Sylviane Olschwang; Sophie Grandjouan; Laetitia Huiart; Michel Longy; Rosine Guimbaud; Bruno Buecher; Yves-Jean Bignon; Olivier Caron; Chrystelle Colas; Catherine Noguès; Sophie Lejeune-Dumoulin; Laurence Olivier-Faivre; Florence Polycarpe-Osaer; Tan Dat Nguyen; Françoise Desseigne; Jean-Christophe Saurin; Pascaline Berthet; Dominique Leroux; Jacqueline Duffour; Sylvie Manouvrier; Thierry Frébourg; Hagay Sobol; Christine Lasset; Catherine Bonaïti-Pellié
Journal:  JAMA       Date:  2011-06-08       Impact factor: 56.272

4.  Strategies to identify the Lynch syndrome among patients with colorectal cancer: a cost-effectiveness analysis.

Authors:  Uri Ladabaum; Grace Wang; Jonathan Terdiman; Amie Blanco; Miriam Kuppermann; C Richard Boland; James Ford; Elena Elkin; Kathryn A Phillips
Journal:  Ann Intern Med       Date:  2011-07-19       Impact factor: 25.391

5.  Fourfold increased detection of Lynch syndrome by raising age limit for tumour genetic testing from 50 to 70 years is cost-effective.

Authors:  A S Sie; A R Mensenkamp; E M M Adang; M J L Ligtenberg; N Hoogerbrugge
Journal:  Ann Oncol       Date:  2014-07-31       Impact factor: 32.976

Review 6.  A systematic review and economic evaluation of diagnostic strategies for Lynch syndrome.

Authors:  Tristan Snowsill; Nicola Huxley; Martin Hoyle; Tracey Jones-Hughes; Helen Coelho; Chris Cooper; Ian Frayling; Chris Hyde
Journal:  Health Technol Assess       Date:  2014-09       Impact factor: 4.014

7.  Recommendations from the EGAPP Working Group: genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives.

Authors: 
Journal:  Genet Med       Date:  2009-01       Impact factor: 8.822

8.  The cost-effectiveness of genetic testing strategies for Lynch syndrome among newly diagnosed patients with colorectal cancer.

Authors:  Mercy Mvundura; Scott D Grosse; Heather Hampel; Glenn E Palomaki
Journal:  Genet Med       Date:  2010-02       Impact factor: 8.822

9.  Economic analyses of genetic tests in personalized medicine: clinical utility first, then cost utility.

Authors:  Scott D Grosse
Journal:  Genet Med       Date:  2013-10-10       Impact factor: 8.822

10.  The economic value of personalized medicine tests: what we know and what we need to know.

Authors:  Kathryn A Phillips; Julie Ann Sakowski; Julia Trosman; Michael P Douglas; Su-Ying Liang; Peter Neumann
Journal:  Genet Med       Date:  2013-10-17       Impact factor: 8.822
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.